“HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer

BACKGROUND: Pancreatic cancer has a dismal prognosis with 5-year overall survival rate of around 5%. Although surgery is still the best option in operable cases, majority of the patients who present in locally advanced stages are deemed inoperable. Novel approaches are therefore needed for the manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Datta, Niloy Ranjan, Pestalozzi, Bernhard, Clavien, Pierre-Alain, Siebenhüner, Alexander, Puric, Emsad, Khan, Shaka, Mamot, Christoph, Riesterer, Oliver, Knuchel, Jürg, Reiner, Cäcilia Sophie, Bodis, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698973/
https://www.ncbi.nlm.nih.gov/pubmed/29162142
http://dx.doi.org/10.1186/s13014-017-0923-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698973/
https://www.ncbi.nlm.nih.gov/pubmed/29162142
http://dx.doi.org/10.1186/s13014-017-0923-8

Ejemplares similares